Homocysteine and folate levels in postmenopausal women
Authors:
- Costas PanoulisCPCostas Panoulis
- Demetrios RizosDRDemetrios Rizos
- Theodor MoustakariasTMTheodor Moustakarias
- Iphigenia PhocasIPIphigenia Phocas
- George CreatsasGCGeorge Creatsas
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Effects of Hormone Replacement Therapy and Raloxifene on C-Reactive Protein and Homocysteine in Healthy Postmenopausal Women: A Randomized, Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2000
- Homocysteine - a pathophysiological cornerstone in obstetrical and gynaecological disorders?Human Reproduction Update, 1999
- Interventions for other risk factors: Tobacco use, physical inactivity, menopause, and homocysteineAmerican Journal of Kidney Diseases, 1998
- Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery diseaseMaturitas, 1998
- Homocysteine and Thrombotic DiseaseBlood, 1997
- Hyperhomocysteinemia and Low Pyridoxal PhosphateCirculation, 1995
- Plasma homocysteine and menopausal status**European Journal of Clinical Investigation, 1995
- Vitamin status and intake as primary determinants of homocysteinemia in an elderly populationJAMA, 1993
- Total homocyst(e)ine in plasma and amniotic fluid of pregnant womenMetabolism, 1986
- Folic acid responsive postmenopausal homocysteinemiaMetabolism, 1985